Atlas Trials

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

Clinical trial NCT07145931 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07145931
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer Squamous Cell CarcinomaSkull Base--CancerNeoadjuvant ChemoimmunotherapyObjective Response Rate
Start date
2025-09-20
Primary completion
2027-09-20
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.